Providers can eliminate the use of gadolinium-based contrast by using new pulse sequences from Toshiba America Medical Systems. The angiography techniques rely on differences in the MR signal that distinguish blood and surrounding soft tissue.
Providers can eliminate the use of gadolinium-based contrast by using new pulse sequences from Toshiba America Medical Systems. The angiography techniques rely on differences in the MR signal that distinguish blood and surrounding soft tissue. The company showcased Fresh Blood Imaging, Contrast-free Improved Angiography, and Time-spatial Labeling Inversion Pulse, positioning these contrast-free imaging techniques as alternatives to gadolinium-based agents. The use of such agents has been associated with the occurrence of nephrogenic systemic fibrosis.
